Composition:1 tablet contains 30 mg ambroxol hydrochloride;
1 effervescent tablet contains 60 mg ambroxol hydrochloride;
5 ml of syrup contains 15 mg ambroxol hydrochloride.
Indications:Mucolytic treatment in acute and chronic bronchial and pulmonary disorders associated with disturbances of mucus production and transport.
Contraindications:hypersensitivity to ambroxol
Responsible entity:Berlin - Chemie AG, Glienicker Weg 125; 12489 Berlin, Germany
Scientific information about the drug:Berlin-Chemie/Menarini Polska Sp. z o.o., ul. Cybernetyki 7; 02-677 Warszawa, tel. (022) 566 21 00, fax (022) 566 21 01
Before use, read the leaflet containing indications, contraindications, data and information concerning adverse effects and dosage, as well as information concerning the use of the medicinal product, or consult a doctor or a pharmacist, because each drug used inappropriately poses a risk for your life and health.